US
Uzuncakmak, Sevgi Karabulut
14 papers · 106 citations · 2022–2025
Publications
14
Citations
106
Years
4
Publications
| Title | Year | Type | Citations |
|---|---|---|---|
|
Investigation of cytochrome B mutations, and <i>UCP2</i> and <i>STC1</i> gene expressions in patients with bipolar disorder
|
2025 | Article | 0 |
|
Does Lrig1 expression have a relationship with ERBB1 and ERBB2 expression in schizophrenia?
|
2025 | Article | 0 |
|
Evaluating STC-1 and STC-2 mRNA expressions in Schizophrenia patients with increased oxidative stress
|
2024 | Article | 0 |
|
Unveiling the significance of Gremlin-1 as a novel biomarker for enhanced severity prediction in COVID-19 patients
|
2024 | Article | 0 |
|
Evaluation of IGFBP5 expression and plasma osteopontin level in COVID-19 patients
|
2023 | Article | 5 |
|
LRIG1 levels in chronic rhinosinusitis with nasal polyps
|
2023 | Article | 1 |
|
Reproductive Effects of <i>S. boulardii</i> on Sub-Chronic Acetamiprid and Imidacloprid Toxicity in Male Rats
|
2023 | Article | 17 |
|
Evaluation Expression of the Caspase-3 and Caspase-9 Apoptotic Genes in Schizophrenia Patients
|
2023 | Article | 35 |
|
Relation of<i> ATPase6</i> Mutations and Telomere Length in Schizophrenia Patients
|
2023 | Article | 3 |
|
Suberosin Alleviates Sepsis-Induced Lung Injury in A Rat Model of Cecal Ligation and Puncture
|
2023 | Article | 12 |
|
CYB mtDNA mutations and expression status of genes in the PI3K/AKT/mTOR signaling pathway in patients with schizophrenia
|
2022 | Article | 1 |
|
Avanafil as a Novel Therapeutic Agent Against LPS-Induced Acute Lung Injury via Increasing CGMP to Downregulate the TLR4-NF-κB-NLRP3 Inflammasome Signaling Pathway
|
2022 | Article | 17 |
|
Preliminary investigation of gene expression levels of PAPP-A, STC-2, and HIF-1α in SARS-Cov-2 infected patients
|
2022 | Article | 5 |
|
Comparison of Serum Adropin Levels in Patients with Diabetes Mellitus, COVID-19, and COVID-19 with Diabetes Mellitus
|
2022 | Article | 10 |